Vivo Bio Tech

Hyderabad, India Founded: 2004 • Age: 22 yrs
CRO providing drug development, discovery and biologic research services
Annual revenue $5.5M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Vivo Bio Tech

Vivo Bio Tech is a company based in Hyderabad (India) founded in 2004. Vivo Bio Tech operates in a competitive market with competitors including GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.

  • Headquarter Hyderabad, India
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Vivo Bio Tech Ltd.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $5.46 M (USD)
    2.69
    as on Mar 31, 2025
  • Net Profit
    $852.48 K (USD)
    188.27
    as on Mar 31, 2025
  • EBITDA
    $2.41 M (USD)
    -3.4
    as on Mar 31, 2025
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Vivo Bio Tech

Vivo Bio Tech is a publicly listed company on the BSE with ticker symbol VIVOBIOT in India, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BSE · Ticker: VIVOBIOT · Sector: Distribution services · India

Funding Insights of Vivo Bio Tech

Investments & Acquisitions by Vivo Bio Tech

Investments

Financial Statements - Vivo Bio Tech

Vivo Bio Tech Comparisons

+
Add Comparison
Available on Premium

Competitors of Vivo Bio Tech

Vivo Bio Tech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of transgenic rodent models and customized cell lines for preclinical development
domain founded_year HQ Location
Humanized mouse models are developed for preclinical immune drug studies.
domain founded_year HQ Location
Animal models are supplied for in-vivo analytical services.
domain founded_year HQ Location
Preclinical CRO services for CNS and orphan disorders are offered.
domain founded_year HQ Location
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
domain founded_year HQ Location
Preclinical contract research organization offering standard GLP and non-GLP services

Frequently Asked Questions about Vivo Bio Tech

Vivo Bio Tech was founded in 2004.

Vivo Bio Tech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Annual revenue of Vivo Bio Tech is $5.46M as on Mar 31, 2025.

Vivo Bio Tech was founded in 2004 and is based in Hyderabad, India, operating as a contract research organization in the pharmaceutical and biotechnology sectors. Services encompass in vitro and in vivo studies, toxicity assessments, pharmacological investigations, and pharmacokineticstoxicokinetics analyses. The biologic research division handles gene synthesis, cloning, recombinant protein expression, purification, and monoclonal antibody production for client needs.

Vivo Bio Tech's top competitors include GenOway, PsychoGenics and PharmaLegacy Laboratories.

Yes, Vivo Bio Tech is publicly traded on BSE under the ticker symbol VIVOBIOT.

The ticker symbol of Vivo Bio Tech is VIVOBIOT on BSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available